Inovio Pharmaceuticals Inc. Stock Slips 4.1%, Underperforms Market

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. shed 4.1% to $1.16 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.2% to 27,190.86 and the Dow Jones Industrial Average rising 0.5% to 51,176.96.

This was the stock's second consecutive day of losses.

Inovio Pharmaceuticals Inc. closed 57.4% below its 52-week high of $2.72, which the company reached on December 17th.

The stock demonstrated a mixed performance when compared to some of its peers, as Johnson & Johnson fell 1.0% to $256.03, Statera Biopharma Inc. fell 99.0% to $0.00, and Pfizer Inc. fell 1.14% to $27.80.

Trading volume totaled 2.9 million, compared to the 50-day average of 4.5 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 02, 2026 16:34 ET (20:34 GMT)